Mode of Delivery in Women With Low-lying Placenta

Low-Lying; Placenta, Hemorrhage, Complicating Delivery Clinical Trial

— MODEL-PLACENTA  

Official title:

Mode of Delivery in Women With Low-lying Placenta: an Italian Multicentre Study

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04827433
• Other study ID #: MODEL-PLACENTA STUDY
• Status: Recruiting
• Start date: October 28, 2020
• Est. completion date: April 28, 2025

Study information

• Verified date: December 2023
• Source: University of Milano Bicocca
• Contact: Elisabetta Colciago
• Phone: 0392332657
• Email: elisabetta.colciago[@]gmail.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Multicentre study; observational, longitudinal prospective, case-control

Description:

This is a new protocol to evaluate the mode of birth in women with a low-lying placenta. In particular, we intend to propose a vaginal birth in women having a low-lying placenta with a distance between the inferior placental edge and the internal cervical os, called internal-os-distance (IOD) of > 5 mm, as assessed in the late III trimester using transvaginal sonography. Duration of the study: - Duration of the study: 54 months - Duration of enrollment: 42 months - Duration of follow-up completion of enrolled cases: 6 months - Duration of data analysis: 6 months Study Design: During the II trimester scan, all women presenting a placenta located in the lower uterine segment will undergo evaluation by Transvaginal Sonography (TVS). If a placenta previa or a low-lying placenta will be confirmed, the woman will be recruited and asked to participate in our study, by signing a written informed consent. In addition women attending the Maternity Triage with vaginal bleeding at < 316/7 weeks of gestation, with a diagnosis of placenta previa or low-lying placenta and not requiring an emergency delivery will be asked to participate and will be recruited after signing the informed consent. An expert Obstetrician will perform the TVS as scheduled, after inviting the woman to void. The assessment will include: - the measurement of the IOD (first caliper on the internal cervical os and second caliper on the inferior placental edge). In case of a marginal sinus, the distance between the internal cervical os and the marginal sinus will also be assessed; - the cervical length (defined as shortened if ≤25 mm); - the placental edge thickness, measured within 1 cm from the meeting point between the basal and the chorionic plate. The placental edge will be considered "thick" if > 1cm or if the angle is >45°. All women with a resolution of a previa or low-lying placenta will be assessed in accordance with the protocol of each participating Maternity Unit, including a scan assessment at 38-39 weeks of gestation or within 28 days from the due date. Calculation of sample size / power: Considering that the incidence of previa and low-lying placenta is approximately 2% at the II trimester scan and 0.4% at birth, and assuming a C.I. of 19% in the probability of vaginal birth in women with low-lying placenta/resolved low-lying (> 20 mm), 27 women will be needed for each participating Maternity Unit at the late III trimester scan. Anticipating a 10% drop out, 30 women will be needed to achieve a 95% statistical power to identify a clinically relevant difference in the rate of vaginal birth. This leads to the need of recruiting 150 women at the II trimester scan. CRF and data management: All data will be recorded through CRF provided by the promoter center and the database will be based on Microsoft Excel. A sample of about 20-30 patients for each enrollment center is necessary to have a statistical power of 95% in detecting a clinically relevant difference in outcomes in the various study groups. Analysis plan: Descriptive statistics will be performed for all variables evaluated in the study population. Variables will be described by mean and standard deviation if normally distributed, otherwise by median and interquantile range; proportions will be used for categorical variables. The quantitative variables, among the study groups defined by the IOD at the last TVS, will be compared by parametric and non-parametric tests, whereas the categorical variables will be compared using Pearson's chi2 test (Fisher exact test where appropriate). The analyses for the primary outcome measure will be performed among women admitted to labor. A multivariate analysis will be conducted to assess the association between obstetric variables and vaginal birth. A p-value<0.05 will be considered significant.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 2550
• Est. completion date: April 28, 2025
• Est. primary completion date: October 28, 2024
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Minimum age of 18
• Women with placenta previa or low-lying placenta confirmed by TVS at 19-23 6/7 weeks of gestation. Women attending Maternity Triage with vaginal bleeding at < 32 weeks of gestation, with a diagnosis of placenta previa or low-lying placenta and not requiring an emergency delivery.
• Women with a normally located placenta at the II trimester ultrasound scan, at 19-23 6/7 week of gestation (control group)
• Single pregnancy
• Signature of the informed consent to participate in the study Note: Women of the "control group" will be recruited in a 1:3 ratio. After the inclusion of 1 case, 3 women with a normally located placenta will be recruited, according to the parity of the woman representing the case (e.g.: 1 CASE= nulliparous woman, 3 CONTROLS= 3 nulliparous women).

Exclusion Criteria:

• Suspected or confirmed invasive placentation (i.e., placenta accreta)
• Vaginal bleeding requiring emergency delivery
• Inability to meet the conditions set out in the study protocol

Related Conditions & MeSH terms

• Hemorrhage
• Low-Lying; Placenta, Hemorrhage, Complicating Delivery

Locations

Country	Name	City	State
Italy	Ospedale Papa Giovanni XXIII	Bergamo
Italy	Fondazione Poliambulanza Istituto Ospedaliero	Brescia
Italy	Ospedale Spedali Civili	Brescia
Italy	Ospedale Vittorio Emanuele III	Carate Brianza
Italy	Ospedale M. Bufalini di Cesena	Cesena
Italy	Ospedale Desio	Desio
Italy	Ospedale Alessandro Manzoni	Lecco
Italy	Ospedale dei Bambini "Vittore Buzzi"	Milan
Italy	Ospedale Mangiagalli	Milan
Italy	Ospedale Niguarda	MIlan
Italy	Ospedale San Raffaele	Milan
Italy	Ospedale Macedonio Melloni	Milano
Italy	Ospedale San Paolo	Milano
Italy	Policlinico di Modena	Modena
Italy	Obstetrics and Gynecology, MBBM Foundation at San Gerardo Hospital	Monza
Italy	Ospedale Infermi di Rimini	Rimini
Italy	Ospedale Filippo Del Ponte	Varese

Sponsors (1)

Lead Sponsor	Collaborator
University of Milano Bicocca

Country where clinical trial is conducted

Italy, 

References & Publications (20)

ACOG Committee Opinion No. 764: Medically Indicated Late-Preterm and Early-Term Deliveries. Obstet Gynecol. 2019 Feb;133(2):e151-e155. doi: 10.1097/AOG.0000000000003083. — View Citation

Al Wadi K, Schneider C, Burym C, Reid G, Hunt J, Menticoglou S. Evaluating the safety of labour in women with a placental edge 11 to 20 mm from the internal cervical Os. J Obstet Gynaecol Can. 2014 Aug;36(8):674-677. doi: 10.1016/S1701-2163(15)30508-9. — View Citation

Alouini S, Megier P, Fauconnier A, Huchon C, Fievet A, Ramos A, Megier C, Valery A. Diagnosis and management of placenta previa and low placental implantation. J Matern Fetal Neonatal Med. 2020 Oct;33(19):3221-3226. doi: 10.1080/14767058.2019.1570118. Epub 2019 Jan 27. — View Citation

Bhide A, Prefumo F, Moore J, Hollis B, Thilaganathan B. Placental edge to internal os distance in the late third trimester and mode of delivery in placenta praevia. BJOG. 2003 Sep;110(9):860-4. — View Citation

Blackwell SC. Timing of delivery for women with stable placenta previa. Semin Perinatol. 2011 Oct;35(5):249-51. doi: 10.1053/j.semperi.2011.05.004. — View Citation

Bronsteen R, Valice R, Lee W, Blackwell S, Balasubramaniam M, Comstock C. Effect of a low-lying placenta on delivery outcome. Ultrasound Obstet Gynecol. 2009 Feb;33(2):204-8. doi: 10.1002/uog.6304. — View Citation

Committee on Obstetric Practice. Committee Opinion No. 713: Antenatal Corticosteroid Therapy for Fetal Maturation. Obstet Gynecol. 2017 Aug;130(2):e102-e109. doi: 10.1097/AOG.0000000000002237. — View Citation

Dashe JS. Toward consistent terminology of placental location. Semin Perinatol. 2013 Oct;37(5):375-9. doi: 10.1053/j.semperi.2013.06.017. — View Citation

Farine D, Fox HE, Jakobson S, Timor-Tritsch IE. Vaginal ultrasound for diagnosis of placenta previa. Am J Obstet Gynecol. 1988 Sep;159(3):566-9. doi: 10.1016/s0002-9378(88)80009-7. — View Citation

Fukuda M, Fukuda K, Shimizu T, Bujold E. Ultrasound Assessment of Lower Uterine Segment Thickness During Pregnancy, Labour, and the Postpartum Period. J Obstet Gynaecol Can. 2016 Feb;38(2):134-40. doi: 10.1016/j.jogc.2015.12.009. Epub 2016 Mar 2. — View Citation

Ginsberg Y, Goldstein I, Lowenstein L, Weiner Z. Measurements of the lower uterine segment during gestation. J Clin Ultrasound. 2013 May;41(4):214-7. doi: 10.1002/jcu.22023. Epub 2013 Mar 16. — View Citation

Jansen C, de Mooij YM, Blomaard CM, Derks JB, van Leeuwen E, Limpens J, Schuit E, Mol BW, Pajkrt E. Vaginal delivery in women with a low-lying placenta: a systematic review and meta-analysis. BJOG. 2019 Aug;126(9):1118-1126. doi: 10.1111/1471-0528.15622. Epub 2019 Mar 10. — View Citation

Jauniaux E, Alfirevic Z, Bhide AG, Belfort MA, Burton GJ, Collins SL, Dornan S, Jurkovic D, Kayem G, Kingdom J, Silver R, Sentilhes L; Royal College of Obstetricians and Gynaecologists. Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green-top Guideline No. 27a. BJOG. 2019 Jan;126(1):e1-e48. doi: 10.1111/1471-0528.15306. Epub 2018 Sep 27. No abstract available. — View Citation

Nakamura M, Hasegawa J, Matsuaka R, Mimura T, Ichizuka K, Sekizawa A, Okai T. Amount of hemorrhage during vaginal delivery correlates with length from placental edge to external os in cases with low-lying placenta whose length between placental edge and internal os was 1-2 cm. J Obstet Gynaecol Res. 2012 Aug;38(8):1041-5. doi: 10.1111/j.1447-0756.2011.01776.x. Epub 2012 May 21. — View Citation

Ohira S, Kikuchi N, Kobara H, Osada R, Ashida T, Kanai M, Shiozawa T. Predicting the route of delivery in women with low-lying placenta using transvaginal ultrasonography: significance of placental migration and marginal sinus. Gynecol Obstet Invest. 2012;73(3):217-22. doi: 10.1159/000333309. Epub 2012 Mar 1. — View Citation

Oppenheimer L, Holmes P, Simpson N, Dabrowski A. Diagnosis of low-lying placenta: can migration in the third trimester predict outcome? Ultrasound Obstet Gynecol. 2001 Aug;18(2):100-2. doi: 10.1046/j.1469-0705.2001.00450.x. — View Citation

Oppenheimer L; MATERNAL FETAL MEDICINE COMMITTEE. RETIRED: Diagnosis and management of placenta previa. J Obstet Gynaecol Can. 2007 Mar;29(3):261-266. doi: 10.1016/S1701-2163(16)32401-X. — View Citation

Oppenheimer LW, Farine D. A new classification of placenta previa: measuring progress in obstetrics. Am J Obstet Gynecol. 2009 Sep;201(3):227-9. doi: 10.1016/j.ajog.2009.06.010. No abstract available. — View Citation

Reddy UM, Abuhamad AZ, Levine D, Saade GR; Fetal Imaging Workshop Invited Participants. Fetal imaging: executive summary of a joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, American Institute of Ultrasound in Medicine, American College of Obstetricians and Gynecologists, American College of Radiology, Society for Pediatric Radiology, and Society of Radiologists in Ultrasound Fetal Imaging Workshop. J Ultrasound Med. 2014 May;33(5):745-57. doi: 10.7863/ultra.33.5.745. — View Citation

Silver RM. Abnormal Placentation: Placenta Previa, Vasa Previa, and Placenta Accreta. Obstet Gynecol. 2015 Sep;126(3):654-668. doi: 10.1097/AOG.0000000000001005. — View Citation

* Note: There are 20 references in all — Click here to view all references

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Incidence of vaginal delivery and urgent cesarean section	Rate of vaginal birth and emergency cesarean section in labor due to vaginal bleeding	Until the end of the study (approximately 54 months).
Secondary	Frequency of resolution of placenta previa or low-lying	Frequency of resolution of placenta previa or low-lying in relation to the placental location at the time of diagnosis and in relation to maternal history of hysterotomy	Until the end of the study (approximately 54 months).
Secondary	Placental migration speed and its correlation with different variables	Description of time needed for resolution of previa or low-lying placenta in relation to placental location at diagnosis (anterior/posterior; praevia/low-lying), and maternal history of hysterotomy, and its correlation to the mode of birth and risk of bleeding during pregnancy and in labor.	Until the end of the study (approximately 54 months).
Secondary	Frequency of ultrasound visualization of the marginal breast in low-lying placentas and other variables	Frequency of marginal sinus in women with low-lying placenta and its relation with mode of birth and risk of ante-, intra-, and post-partum bleeding.	Until the end of the study (approximately 54 months).
Secondary	Refusal of elective caesarean section	Rate of women declining the mode of birth suggested by clinicians during counselling.	Until the end of the study (approximately 54 months).
Secondary	Morbidity associated with the various groups of placental distance analyzed by the antepartum hemorrhage incidence.	Incidence of antepartum hemorrhage requiring hospital admission or immediate delivery.	Until the end of the study (approximately 54 months).
Secondary	Morbidity associated with the various groups of placental distance studied with the intrapartum hemorrhage incidence.	Incidence of intrapartum hemorrhage requiring emergency CS.	Until the end of the study (approximately 54 months).
Secondary	Morbidity associated with the various groups of placental distance through the severe postpartum hemorrhage incidence.	Incidence of severe postpartum hemorrhage, defined as bleeding = 1000 ml following birth and administration of uterotonic drugs, use of balloon tamponade, uterine artery embolization, ligature of uterine arteries, hysterectomy, blood transfusion;	Until the end of the study (approximately 54 months).
Secondary	Morbidity associated with the various groups of placental distance associated with the admission to Intensive Care Unit (ICU)	The maternal admission to ICU.	Until the end of the study (approximately 54 months).
Secondary	Morbidity associated with the various groups of placental distance described by the preterm bith incidence	Incidence of preterm birth can described the morbidity associated wiith the various groups of placenta distance.	Until the end of the study (approximately 54 months).
Secondary	Morbidity associated with the various groups of placental distance described through the preterm incidence less than 32 weeks.	Incidence of preterm birth < 32 weeks.	Until the end of the study (approximately 54 months).
Secondary	Morbidity associated with the various groups of placental distance according to the neonatal admission to ICU	Neonatal admission to Neonatal ICU and length of stay.	Until the end of the study (approximately 54 months).